会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • DERMAL PEEL-FORMING FORMULATION
    • DERMAL PEEL-FORMING制剂
    • WO2005120473A3
    • 2006-05-11
    • PCT/US2005020099
    • 2005-06-07
    • ZARS INCZHANG JIEWARNER KEVIN SASHBURN MICHAEL ARIGBY LARRY DNIU SUYI
    • ZHANG JIEWARNER KEVIN SASHBURN MICHAEL ARIGBY LARRY DNIU SUYI
    • A61F13/00A61K9/70
    • A61K9/7015A61K31/167A61K31/192A61K31/196A61K31/445A61K31/573A61K47/10A61K47/32
    • The present invention is drawn to adhesive peel-forming formulations for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a peel-forming agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein the non-volatile solvent system has a solubility for the drug that is within a window of operable solubility for the drug such that the drug can be delivered at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified peelable layer after at least a portion of the volatile solvent system is evaporated.
    • 本发明涉及用于药物真皮递送的粘合剂剥离形成制剂。 制剂可以包括药物,溶剂载体和剥离形成剂。 溶剂载体可以包括具有一种或多种挥发性溶剂的挥发性溶剂体系和具有一种或多种非挥发性溶剂的非挥发性溶剂体系,其中所述非挥发性溶剂体系对于在窗口内的药物具有溶解性 对于药物具有可操作的溶解性,使得药物可以在持续的时间段内以治疗有效的速率递送。 在挥发性溶剂体系蒸发之前,配方可以具有适用于皮肤表面的粘度。 当施用于皮肤时,在挥发性溶剂系统的至少一部分蒸发之后,制剂可以形成固化的可剥离层。
    • 3. 发明申请
    • REDUCTION OF UNINTENDED USE OF TRANSDERMAL DEVICES
    • 减少意外使用变形设备
    • WO2005041883A3
    • 2005-11-17
    • PCT/US2004036131
    • 2004-10-28
    • ZARS INCWARNER KEVIN SASHBURN MICHAEL ANIU SUYI
    • WARNER KEVIN SASHBURN MICHAEL ANIU SUYI
    • A61F13/00A61K20060101A61K9/70A61K49/00
    • A61K9/7023B09B3/0075B09B2220/14
    • The present invention is drawn to systems and methods for reducing unintended use of an active ingredient, such as residual active ingredients present in spent dermal patches and peels. The system can include a dermal patch including an active ingredient and a destructive agent configured to chemically react with the active ingredient. The destructive agent can be present in a container or an absorber. In one embodiment, the absorber can be used within the container. The container can be configured to receive the dermal patch such that the active ingredient contacts the destructive agent within the container. The absorber can be configured to contact the dermal patch such that the active ingredient contacts the destructive agent of the absorber. Additionally, systems and methods for impeding the unintended use of an active ingredient, such as those present in dermal patches or peels, are also provided. The system includes a dermal patch having a first side configured to deliver an active ingredient to a skin or mucosal surface, wherein the first side also includes a dermal adhesive. The system also includes an adhesive-coated device. The adhesive-coated surface of the device can be configured to adhere to the first side, wherein upon use of the dermal patch followed by contacting the adhesive-coated surface with the first side, residual active ingredient is rendered substantially inaccessible.
    • 本发明涉及用于减少活性成分的非预期用途的系统和方法,所述活性成分例如存在于有效皮肤贴剂和皮肤中的残留活性成分。 该系统可以包括皮肤贴片,其包括配置成与活性成分发生化学反应的活性成分和破坏剂。 破坏剂可存在于容器或吸收器中。 在一个实施例中,吸收器可以在容器内使用。 容器可以被配置为接收皮肤贴片,使得活性成分与容器内的破坏剂接触。 吸收器可以被配置为接触皮肤贴片,使得活性成分与吸收体的破坏剂接触。 此外,还提供了用于阻止意图使用活性成分(例如存在于真皮贴剂或皮肤中的那些)的系统和方法。 该系统包括皮肤贴片,其具有构造成将活性成分递送至皮肤或粘膜表面的第一侧,其中第一面还包括真皮粘合剂。 该系统还包括涂有粘合剂的装置。 装置的粘合剂涂覆的表面可以被配置为粘附到第一侧,其中在使用皮肤贴片然后使粘合剂涂覆的表面与第一面接触时,残留的活性成分基本上不可接近。
    • 4. 发明申请
    • FLUX-ENABLING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS
    • 助燃剂组合物和用于药物递送的方法
    • WO2007070695A3
    • 2008-08-21
    • PCT/US2006048061
    • 2006-12-14
    • ZARS INCZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • ZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • A61K8/02A61F13/00
    • A61K9/7015A61K9/0014A61K9/0017
    • The present invention is drawn to adhesive solidifying formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system comprising at least one volatile solvent, and a non-volatile solvent system comprising at least one non-volatile solvent, wherein at least one non-volatile solvent is a flux-enabling non-volatile solvent(s) capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
    • 本发明涉及粘合剂凝固制剂,药物递送方法和用于药物真皮递送的固化层。 制剂可以包括药物,溶剂载体和固化剂。 溶剂载体可以包括包含至少一种挥发性溶剂的挥发性溶剂体系和包含至少一种非挥发性溶剂的非挥发性溶剂体系,其中至少一种非挥发性溶剂是助熔剂非挥发性溶剂( s),其能够在持续的时间段内以治疗有效率促进药物的递送。 在挥发性溶剂体系蒸发之前,配方可以具有适用于皮肤表面的粘度。 当施用于皮肤时,在挥发性溶剂体系的至少一部分蒸发后,制剂可以形成固化层。
    • 5. 发明申请
    • COMPOSITIONS AND METHODS FOR DERMALLY TREATING PAIN
    • 用于牙痛治疗的组合物和方法
    • WO2007070679A3
    • 2009-01-08
    • PCT/US2006047926
    • 2006-12-14
    • ZARS INCZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • ZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • A01N37/12
    • A61K9/0014A61K47/10A61K47/18
    • The present invention is drawn to solidifying formulations for dermal delivery of a drug for treating pain, such as musculoskeletal pain, inflammation, joint pain, or neuropathic pain. The formulation can include a drug selected from certain drug classes, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system comprising at least one volatile solvent, and a non-volatile solvent system comprising at least one non-volatile solvent, wherein the evaporation of at least some of the volatile solvent converts the formulation on the skin into a solidified layer and the non-volatile solvent system is capable of facilitating the topical delivery of the drug(s) at therapeutically effective rates over a sustained period of time.
    • 本发明涉及用于皮肤递送用于治疗疼痛的药物如肌肉骨骼疼痛,炎症,关节疼痛或神经性疼痛的固化制剂。 制剂可以包括选自某些药物类别的药物,溶剂载体和固化剂。 溶剂载体可以包括包含至少一种挥发性溶剂的挥发性溶剂体系和包含至少一种非挥发性溶剂的非挥发性溶剂体系,其中至少一些挥发性溶剂的蒸发将皮肤上的制剂转化成 固化层和非挥发性溶剂体系能够在持续的时间内以治疗有效的速率促进药物的局部递送。
    • 7. 发明申请
    • INSTANT PATCH FOR DERMAL DRUG DELIVERY
    • 用于皮肤药物递送的即时贴剂
    • WO2006053222A3
    • 2006-08-31
    • PCT/US2005040938
    • 2005-11-11
    • ZARS INCZHANG JIEWARNER KEVIN S
    • ZHANG JIEWARNER KEVIN S
    • A61F13/00A61F13/02
    • A61K9/703A61K9/7084A61L15/16A61L15/44A61L15/60A61L2300/40A61L2300/602
    • The present invention is drawn toward systems, devices, and methods of dermal drug delivery. The system can comprise a gel-triggering agent and a drug-containing composition including a drug and a gelling agent, wherein the drug-containing composition forms a soft, coherent solid when contacted with the gell-triggering agent. A cavity patch (10) is also included having an open cavity (18) configured to be closed at least in part by a skin surface (44). The open cavity can be further configured to facilitate contact between the skin surface and the gel. The gel-triggering agent and the drug-containing composition can be positioned in the system such that they are kept isolated from one another until immediately before or during use.
    • 本发明涉及皮肤给药的系统,装置和方法。 该系统可以包含凝胶触发剂和包含药物和胶凝剂的含药物组合物,其中当与凝胶触发剂接触时,含药物组合物形成柔软的粘附固体。 还包括空腔补片(10),其具有构造成至少部分地由皮肤表面(44)封闭的开放空腔(18)。 开放腔可以进一步配置成促进皮肤表面和凝胶之间的接触。 凝胶触发剂和含有药物的组合物可以位于系统中,使得它们在使用前或使用过程中保持彼此隔离。
    • 9. 发明申请
    • COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL CONDITIONS
    • 用于治疗皮肤病症的组合物和方法
    • WO2007070643A3
    • 2008-05-08
    • PCT/US2006047747
    • 2006-12-14
    • ZARS INCZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • ZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • A61K9/12A61K31/74
    • A61K9/0014A61K9/7015
    • The present invention is drawn to solidifying adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug which can treat various dermatological conditions, such as a bacterial infection, a virus infection, a fungal infection, alopecia, dermatitis, psoriasis, or photo damaged skin. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent. The non-volatile solvent system can facilitate the delivery of the drug at therapeutically effective rates for sustained period of time. The non-volatile solvent system can also act as a plasticizer for the solidifying agent. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
    • 本发明涉及固化粘合剂制剂,药物递送方法和用于皮肤递送药物的固化层,其可以治疗各种皮肤病学条件,例如细菌感染,病毒感染,真菌感染,脱发,皮炎,牛皮癣 ,或照片损伤的皮肤。 制剂可以包括药物,溶剂载体和固化剂。 溶剂载体可以包括包含至少一种挥发性溶剂的挥发性溶剂体系和包含至少一种非挥发性溶剂的非挥发性溶剂体系。 非挥发性溶剂体系可以有助于以治疗有效率持续持续的时间递送药物。 非挥发性溶剂体系也可以作为固化剂的增塑剂。 在挥发性溶剂体系蒸发之前,配方可以具有适用于皮肤表面的粘度。 当施用于皮肤时,在挥发性溶剂体系的至少一部分蒸发后,制剂可以形成固化层。
    • 10. 发明申请
    • COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS
    • 用于药物递送的组合物和方法
    • WO2007100376A2
    • 2007-09-07
    • PCT/US2006048059
    • 2006-12-14
    • ZARS INCZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • ZHANG JIEWARNER KEVIN SSHARMA SANJAY
    • A61K9/0014A61K9/7015A61K47/06A61K47/10A61K47/12A61K47/14A61K47/32A61K47/38A61K47/44
    • The present invention is drawn to adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and at least one solidifying agent. The solvent vehicle can have a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent. The formulation can be formulated to contain at least two volatile solvents, at least two non-volatile solvents, or at least two solidifying agents. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
    • 本发明涉及粘合剂制剂,药物递送方法和用于药物真皮递送的固化层。 制剂可以包括药物,溶剂载体和至少一种固化剂。 溶剂载体可以具有包括至少一种挥发性溶剂的挥发性溶剂体系和包含至少一种非挥发性溶剂的非挥发性溶剂体系。 制剂可配制成含有至少两种挥发性溶剂,至少两种非挥发性溶剂或至少两种固化剂。 在挥发性溶剂体系蒸发之前,配方可以具有适用于皮肤表面的粘度。 当施用于皮肤时,在挥发性溶剂体系的至少一部分蒸发后,制剂可以形成固化层。